The activation of STAT3 is among the pathways proposed to be involved in the development of drug resistance in oncogene-addicted tumor cells, although the specific mechanism is still unclear: STAT3 could be activated to prevent apoptosis and sustain cell viability but it may also be activated early in a cancer-cell sub-population, maybe immediately after drug exposure [34]. The gene discussed is STAT3; the disease is cancer.